|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
Biogen Idec Reaches Deal With Icahn, Ironwood CEO Shares IPO Strategy, Luke Maps out the Genetics Institute Diaspora, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
03/26/10 |
Boston
|
|
The Genetics Institute Alumni: Where Are They Now?
|
Luke Timmerman |
03/22/10 |
Boston
|
|
Proteostasis, a Rich Boston Biotech with San Diego Ties, Grows to Pursue Diseases of Aging
|
Luke Timmerman |
02/18/10 |
Boston
|
|
Zafgen Plans Weight-Loss Study, Infinity CEO Perkins Plans for Growth, Boston Scientific Cuts 1000+ Jobs, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
02/12/10 |
Boston
|
|
Infinity’s New CEO, Veteran Dealmaker, Seeks to Deliver on Company’s Early Promise
|
Luke Timmerman |
02/09/10 |
Boston
|
|
A Graceful Exit for Gloucester, Pink Slips at Sermo, A Half a Billion Bucks for Vertex, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
12/09/09 |
Boston
|
|
Infinity Names New CEO
|
Luke Timmerman |
12/07/09 |
Boston
|
|
The Boston Biotech Survival Index: Big Fish Still Swimming, Minnows Getting Eaten
|
Luke Timmerman |
10/08/09 |
Boston
|
|
Biotech Startup Acetylon Pharma Catches $7.25M in A Round from Backers Such As New England Patriots Owner
|
Ryan McBride |
08/07/09 |
Boston
|
|
Biogen Idec, Trying to Go Beyond Rituxan, Assembles Cancer Drug Pipeline
|
Luke Timmerman |
07/16/09 |
Boston
|
|
GSK Cuts Deal with Concert to the Tune of a Potential $1B, Celldex Inks $94.5M CuraGen Acquisition, Aveo Touts Kidney Cancer Drug Data, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
06/03/09 |
Boston
|
|
ASCO Weekend Highlights: ImmunoGen, Antigenics, Aveo Show Off Cancer Drug Findings
|
Luke Timmerman |
06/01/09 |
Boston
|
|
Infinity Sees Comeback Potential for Cancer Drug that Failed
|
Luke Timmerman |
06/01/09 |
Boston
|
|
Biogen Idec Rebuts Icahn Attack, GlaxoSmithKline Quietly Spins Off Tempero Pharmaceuticals, Knome Launches Cheaper Sequencing Service, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
05/20/09 |
Boston
|
|
ASCO Sneak Peek: ImmunoGen, Biogen Idec, Infinity Show Glimpses of Cancer Drug Data
|
Luke Timmerman |
05/15/09 |
Boston
|
|
Group Names IBM, Zeemote, Infinity, Wolfe Executives as Leading Women Entrepreneurs
|
Wade Roush |
05/05/09 |
Boston
|
|
Innovating Through the Downturn: The View from the Nantucket Conference
|
Wade Roush |
05/05/09 |
Boston
|
|
Infinity Halts Trial of Lead Cancer Drug, Tysabri Sales Short of Projections, Myomo Slashes Staff, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
04/22/09 |
Boston
|
|
Infinity Pharma Lead Cancer Drug Trial Halted, Ends in Failure
|
Ryan McBride |
04/15/09 |
Boston
|
|
Biotech Survival Index 2: Boston Life Sciences Companies Squirrel Away More Cash for Long Winter
|
Luke Timmerman |
03/17/09 |
Boston
|
|
Biogen Idec Parkinson’s Drug Hits Goal in Pair of Mid-Stage Trials
|
Luke Timmerman |
01/13/09 |
Boston
|
|
Genzyme and Boston Scientific Get Good News From the FDA; Acusphere and Targanta Not So Much; TransMedics Pulls IPO Plug; & More Boston-Area Life Sciences News
|
Rebecca Zacks |
12/17/08 |
Boston
|
|
Infinity Pharmaceuticals Gets Back Full Rights to Cancer Drugs From AstraZeneca
|
Luke Timmerman |
12/11/08 |
Boston
|
|
Resolvyx Closes in on Clinical Trials, Radius Health Reels in $15M, Luke Zeros in on Public Biotechs’ Bottom Line, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
11/26/08 |
Boston
|
|
Biotech Survival Index: Boston Life Sciences Companies Brace for Long, Hard Winter
|
Luke Timmerman |
11/25/08 |
Boston
|
|
SunEthanol Picks Up $25M, New Name; Infinity Pharma Pairs with Purdue Pharma; In-Q-Tel Taps Two Local Firms, & More Boston-Area Deals News
|
Rebecca Zacks |
11/24/08 |
Boston
|
|
Vertex, Ariad, and Infinity Reach Clinical Milestones; FDA Grants Dying Cancer Patient Access to Tysabri; Genzyme Exec Takes Pervasive Helm; & More Boston-Area Life Sciences News
|
Rebecca Zacks |
10/22/08 |
Boston
|
|
Infinity Starts Trial of Hedgehog Pathway Blocker
|
Luke Timmerman |
10/16/08 |
Boston
|
|
Vertex Cystic Fibrosis Program on the Rise, Biogen and Partner Fall on Tysabri News, Alnylam Stakes RNAa IP Claim, & More Life Sciences News
|
Rebecca Zacks |
08/06/08 |
Boston
|
|
Infinity Pharmaceuticals Starts First Clinical Trial of Oral Hsp-90 Blocker
|
Luke Timmerman |
07/30/08 |
Boston
|
|
Page 2 of
3 |
« previous page · next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.